(A) Axial and (B) coronal reformatted images from CT performed with IV contrast material show segmental visualization of main pancreatic duct (arrow). One of three reviewers described main duct dilation as present. Agreement among reviewers on CT for main duct dilatation was substantial (κ=0.63).

March 9, 2022 — According to an open-access Editor’s Choice article in ARRS’ American Journal of Roentgenology (AJR), interobserver agreement proved generally fair to moderate for most CT and MRI findings of chronic pancreatitis in children.

“This study highlights challenges for the imaging diagnosis of pediatric chronic pancreatitis,” wrote first author Andrew T. Trout of Cincinnati Children's Hospital Medical Center in Ohio. “Standardized and/or objective criteria are needed, given the importance of imaging in diagnosis.”

In Trout et al.’s retrospective study, CT or MRI examinations performed in children with chronic pancreatitis were submitted by six sites participating in the INternational Study Group of Pediatric Pancreatitis: In search for a cuRE (INSPPIRE) consortium. One board-certified pediatric radiologist from each of the six sites participated in independent image review. Three radiologists independently reviewed only CT examinations, whereas three other radiologists independently reviewed just MRI examinations. While measuring pancreas thickness and duct diameter, reviewers evaluated 13 categorical subjective features: 12 on both CT and MRI, 1 on CT only, 1 on MRI only.

In this study of six sites in the INSPPIRE consortium, interobserver agreement for findings of chronic pancreatitis in children was relatively high for CT for the presence of parenchymal calcifications (κ=0.81), pancreatic duct dilation (κ=0.63), and atrophy (κ=0.52); and for MRI for main and side branch pancreatic duct findings (κ=0.64-0.74).

Noting that duct findings showed the highest levels of agreement for both modalities, “agreement for subjective findings of atrophy was moderate, and agreement for parenchymal thickness (a quantitative measure of atrophy) depended on the location of measurement, with the best agreement observed in the pancreatic body,” the authors of this AJR article concluded.

For more information: www.arrs.org


Related Content

News | Lung Imaging

April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...

Time April 17, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | SPECT Imaging

Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...

Time February 05, 2025
arrow
News | Radiology Imaging

Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...

Time January 27, 2025
arrow
News | Contrast Media

Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...

Time January 14, 2025
arrow
News | Computed Tomography (CT)

Dec. 3, 2024 — During RSNA '24, GE HealthCare announced the 510(k) submission to the U.S. Food and Drug Administration ...

Time December 18, 2024
arrow
News | SPECT Imaging

Dec. 2, 2024 — GE HealthCare has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing ...

Time December 05, 2024
arrow
News | RSNA

Nov. 13, 2024 — Agfa Radiology Solutions will feature live demonstrations of state-of-the-art digital X-ray rooms ...

Time November 14, 2024
arrow
News | Women's Health

Aug. 19, 2024 — GE HealthCare recently announced a collaboration with the University of California San Diego School of ...

Time August 29, 2024
arrow
News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
Subscribe Now